| UNITED THERAPEUTICS |
| USA |
| Gesundheit |
| US91307C1027 / 923818 |
| UTH (Frankfurt) / UTHR (NASDAQ) |
| FRA:UTH, ETR:UTH, UTH:GR, NASDAQ:UTHR |
| - |
| http://www.unither.com/ |
|
United Therapeutics Corporation is a biotechnology company specializing in therapies for pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease, and other serious conditions. Founded in 1996 and headqu..
>Volltext.. |
| 20424.76 Mio. EUR |
| 18553.78 Mio. EUR |
| 2765.81 Mio. EUR |
| 1350.01 Mio. EUR |
| 1123.32 Mio. EUR |
| 25.59 EUR |
| - |
| 937.29 Mio. EUR |
| 1364.06 Mio. EUR |
| 3.59 |
| -0.87% |
| -0.43% |
| - |
| - |
| - |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 148.169.378 Euro. |
| UNITED THERAPEUTICS, UNITED THERAPEUTIC, UNITED THERA |
| 19.06.26 |
|